Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,109,832
+$2,328,891 QoQ
Shares Held
112,856
+130.8% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#271
of 1,412 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAXTON ASSOCIATES LLP holds $23,868,011 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (34.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
112,856 | $8,109,832 | |
| 2 | LQDA |
Liquidia Corp
|
92,656 | $7,387,462 | |
| 3 | VTRS |
Viatris Inc
|
255,423 | $4,056,117 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
21,854 | $2,424,482 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
56,917 | $1,443,984 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
9,438 | $446,134 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,109,832 | 112,856 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,780,941 | 48,904 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,171,401 | 17,258 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $415,695 | 2,841 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $438,687 | 2,813 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $929,778 | 5,647 | Shares | Sole | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||